Want to see HK:6660 full AI Analyst Report?
AIM Vaccine Co., Ltd. Class H (6660) Revenue
AIM Vaccine Co., Ltd. Class H Revenue
AIM Vaccine Co., Ltd. Class H had a revenue of 345.79M in the quarter ending Jun 30, 2026, with -46.88%. This bring the company's revenue in the last twelve months to 996.81M, Decreased 14.49%. In the fiscal year ending Dec 31, 2025, AIM Vaccine Co., Ltd. Class H had annual revenue of 1.15B with -10.17% growth.
- Revenue (ttm)
- 996.81M
- Revenue Growth
- -18.45%
- P/S Ratio
- 1.63
- Revenue/Employee
- HKD 787,408
- Employees
- 1,466
- Market Cap
- HKD 1.88B
Revenue Chart
AIM Vaccine Co., Ltd. Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.15B | -130.69M | -10.17% |
| Dec 31, 2024 | 1.29B | 97.56M | 8.22% |
| Dec 31, 2023 | 1.19B | -76.61M | -6.06% |
| Dec 31, 2022 | 1.26B | -306.06M | -19.49% |
| Dec 31, 2021 | 1.57B | -67.84M | -4.14% |
| Dec 31, 2020 | 1.64B | 686.32M | 72.12% |
| Dec 31, 2019 | 951.65M | -157.96M | -14.24% |
| Dec 31, 2018 | 1.11B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.